Bayer BAYRY announced that finerenone achieved the primary endpoint in the late-stage FIND-CKD study, marking a key milestone ...

With a fresh phase 3 win for Kerendia, Bayer is one step closer to pushing the ascendant drug into a much broader population ...

Add Yahoo as a preferred source to see more of our stories on Google. The logo of German pharmaceuticals and chemicals giant Bayer stands over company offices in Berlin, Germany. An experimental ...

Add Yahoo as a preferred source to see more of our stories on Google. Bayer's drug candidate to ease menopausal hot flashes was deemed safe and effective for long-term use in study results released ...

(Bloomberg) -- Bayer AG said an experimental stroke-prevention drug showed positive results in a late-stage study, a boost for the German company as it seeks to counter sales declines from aging ...

Bayer AG reported positive results for elinzanetant in women with or at high risk of a type of breast cancer, broadening the use case for the menopause treatment expected to launch as early as this ...

A combination featuring Exelixis’ experimental drug zanzalintinib has beaten Bayer’s gastrointestinal cancer med Stivarga in a phase 3 trial. The overall survival win moves Exelixis a step closer to ...

For those who have experienced a stroke, the chances of a second one are high. An experimental Bayer drug reduced this risk by 26% in a pivotal trial, supporting the case for this pill as a potential ...

Bayer shares rose on Monday after the company said a late-stage trial of a stroke drug met its goals. Bayer stock jumped on Monday after the German healthcare company said a late-stage stroke drug ...